Company profilePharmaceutical#898 of 1,318 in Pakistan✓ No DRAP alerts

HATAF PHARMA

Pharmaceutical company · 6 brands · 9 molecules

Ranked #131 of 146 companies in Antiemetics & Antinauseants

6 registered products 9 pharmaceutical brands 9 distinct molecules 0 DRAP alerts

Company overview

6
registered products
9
pharmaceutical brands
9
distinct molecules
2
therapeutic classes
0
DRAP alerts

HATAF PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 6 product registrations across 9 distinct molecules. Its portfolio is concentrated in Antiemetics & Antinauseants and Multivitamin Without Mineral. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Diclofenac1 brand
Tazobactam1 brand
Omeprazole1 brand
Folic Acid1 brand
Ferrous1 brand

Therapeutic classes

Antiemetics & Antinauseants · 1Multivitamin Without Mineral · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for HATAF

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.